About
Acceptance Rate:
33%
Time to first decision with review:
35 days*
Acceptance to publication:
22 days*
Impact Factor:
3.7
Citescore:
5.3
Aims and scope
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
Editorial Board
For information about Lupus Science & Medicine’s joint Editors-in-Chief, and their editorial team, please refer to the Editorial Board page.
Ownership
Lupus Science & Medicine® is published by BMJ and owned by the Lupus Foundation of America, which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.
“Lupus Science & Medicine” is a Registered Trademark.
Journal information
Publication Model
Open access
Frequency
Continuous online publication
Launch date
2014
Indexed by
Web of Science Core Collection: Science Citation Index Expanded; Emerging Sources Citation Index, Current Contents: Clinical Medicine, Medline (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), DOAJ, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Online ISSN
2053-8790
Journal Statistics 2023
Acceptance rate: 33%
Speed
Time to first decision without review (median): 5 days
Time to first decision with review (median): 35 days
Time from acceptance to publication (median): 22 days
Impact
Impact Factor Category: Rheumatology
Impact Factor (JCR): 3.7
Impact Factor rank: 14/57
5 Year Impact Factor: 3.5
Journal Citation Indicator: 0.92
Eigenfactor Score: 0.00302
Scimago Journal rank (SJR): 1.278
Citescore: 5.3
Citescore rank: 24/73
Reach
Total content views: 141,273
Total Altmetric mentions: 1,054
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact Information
For all contact information please refer to the contact us page.
For Authors
Please refer to the Instructions for authors
To advertise
Rights and Permissions
Affiliations
Lupus Foundation of America
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.